SEARCH RESULTS FOR: "Tag: SGMO"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(3)
2018(4)
2017(5)
CATEGORIES
Analyst Update(3)
Analyst Upgrades(1)
Buzz Stocks(1)
Quantitative Analysis(2)
Stocks On the Move(6)
Technical Analysis(1)

7/8/2019 9:53 AM
Two biotech names are making a run up the Nasdaq charts this morning. First there's Sangamo Therapeutics Inc (NASDAQ:SGMO), up 10% to trade at $12.53, after the gene therapy specialist reported positi...
3/12/2019 12:23 PM
Biotech company Sangamo Therapeutics Inc (NASDAQ:SGMO) just named Jason Fontenot, Ph.D. as its Senior Vice President, Cell Therapy. Fontenot will be in charge of the genomic medicine concern's develo...
2/7/2019 2:58 PM
Stocks are staring at stiff losses following fresh U.S.-China trade news. Among individual names making big moves lower are ePort parent USA Technologies, Inc. (NASDAQ:USAT), biotech Sangamo Therap...
9/5/2018 2:53 PM
It's a mixed trading day on Wall Street, with the tech sector lagging on regulatory concerns. Among individual stocks making volatile moves are genome editing firm Sangamo Therapeutics Inc (NASDAQ:S...
4/19/2018 1:15 PM
Biotech stock Sangamo Therapeutics Inc (NASDAQ:SGMO) touched a 17-year high of $27.50 on Feb. 22, after the company announced a $3 billion gene-editing deal with Gilead Sciences (GILD). Since then,...
 
Special Offers from Schaeffer's Trading Partners